/Equipment%20and%20medical%20devices%20in%20hybrid%20operating%20room%20by%20%E5%AE%89%E7%90%A6%20%E7%8E%8B%20via%20Adobe%20Stock.jpeg)
Revvity, Inc. (RVTY) is a life sciences and diagnostics company that develops technologies, software, and services supporting the entire healthcare continuum, from scientific discovery and drug development to disease detection and diagnosis. Its expertise spans translational multi-omics, biomarker identification, imaging, screening, diagnostics, and informatics, helping researchers and healthcare providers advance precision medicine.
Revvity generated $2.9 billion in revenue in 2025, employs approximately 11,000 people, and serves pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations across more than 160 countries. Currently carrying a market capitalization of approximately $12.69 billion, Revvity is preparing to report its fiscal 2026 second-quarter results in the near term.
